Socioeconomic inequalities in prostate cancer survival: A review of the evidence and explanatory factors

Social Science and Medicine

Volumn 142, Issue , 2015, Pages 9-18

  Klein, Jens ^a   von dem Knesebeck, Olaf ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

Explanatory factors; Mediating effects; Prostate cancer; Socioeconomic status; Survival inequalities; Systematic review

Indexed keywords

CANCER; PUBLIC HEALTH; SOCIOECONOMIC STATUS; SURVIVAL;

CANCER PROGNOSIS; CANCER STAGING; CANCER SURVIVAL; COMMUNITY LIVING; COMORBIDITY; CROWDING (AREA); DISEASE ASSOCIATION; EDUCATIONAL STATUS; HEALTH BEHAVIOR; HEALTH CARE ACCESS; HUMAN; INCOME; MEDICAL INFORMATION; OCCUPATION; POVERTY; PROSTATE CANCER; PUBLIC HEALTH; REVIEW; SOCIAL SECURITY; SOCIOECONOMICS; UNEMPLOYMENT; ECONOMICS; HEALTH CARE DELIVERY; HEALTH DISPARITY; MALE; MORTALITY; PROSTATE TUMOR; SOCIAL CLASS; SURVIVAL RATE;

HEALTH SERVICES ACCESSIBILITY; HEALTH STATUS DISPARITIES; HUMANS; MALE; PROSTATIC NEOPLASMS; SOCIAL CLASS; SOCIOECONOMIC FACTORS; SURVIVAL RATE;

EID: 84939423801     PISSN: 02779536     EISSN: 18735347     Source Type: Journal    
DOI: 10.1016/j.socscimed.2015.07.006     Document Type: Review

References (120)

1. Aarts M.J., Kamphuis C.B.M., Louwman M.J., Coebergh J.W.W., Mackenbach J.P., van Lenthe F.J. Educational inequalities in cancer survival: a role for comorbidities and health behaviours?. J. Epidemiol. Community Health 2013, 67:365-373.
2. Aarts M.J., Koldewijn E.L., Poortmans P.M., Coebergh J.W.W., Louwman M. The impact of socioeconomic status on prostate cancer treatment and survival in the southern Netherlands. Urology 2013, 81:593-600.
3. Aarts M.J., van der Aa M.A., Coebergh J.W.W., Louwman W.J. Reduction of socioeconomic inequality in cancer incidence in the south of the Netherlands during 1996-2008. Eur. J. Cancer 2010, 46:2633-2646.
4. Ahmed F.S., Borrell L.N., Spencer B.A. Health risk behaviors and prostate specific antigen awareness among men in California. J. Urol. 2008, 180:658-662.
5. Albano J.D., Ward E., Jemal A., Anderson R., Cokkinides V.E., Murray T., Henley J., Liff J., Thun M.J. Cancer mortality in the United States by education level and race. J. Natl. Cancer Inst. 2007, 99:1384-1394.
6. Albertsen P.C., Hanley J.A.H., Barrows G.H., Penson D.F., Kowalczyk P.D.H., Sanders M.M., Fine J. Prostate cancer and the Will Rogers phenomenon. J. Natl. Cancer Inst. 2005, 97:1248-1253.
7. Australian Institute of Health and Walfare Cancer survival and prevalence in Australia: period estimates from 1982 to 2010. Asia Pac. J. Clin. Oncol. 2013, 9:29-39.
8. Auvinen A., Karjalainen S. Possible explanations for social class differences in cancer patient survival. Social Inequalities and Cancer 1997, 377-397. IARC Sci., Lyon, Publ. No. 138. M. Kogevinas, N. Pearce, M. Susser, P. Boffetta (Eds.).
9. Berglund A., Garmo H., Robinson D., Tishelman C., Holmberg L., Bratt O., Adolfsson J., Stattin P., Lambe M. Differences according to socioeconomic status in the management and mortality in men with high risk prostate cancer. Eur. J. Cancer 2012, 48:75-84.
10. Berglund A., Garmo H., Tishelman C., Holmberg L., Stattin P., Lambe M. Comorbidity, treatment and mortality: a population based cohort study of prostate cancer in PCBaSe Sweden. J. Urol. 2011, 185:833-839.
11. Berry D.A. Failure of researchers, reviewers, editors, and the media to understand flaws in cancer screening studies: application to an article in cancer. Cancer 2014, 120:2784-2791.
12. Bill-Axelson A., Holmberg L., Garmo H., Rider J.R., Taari K., Busch C., Nordling S., Häggman M., Andersson S.-O., Spångberg A., Andrén O., Palmgren J., Steineck G., Adami H.-O., Johansson J.-E. Radical prostatectomy or watchful waiting in early prostate cancer. N. Engl. J. Med. 2014, 370:932-942.
13. Booth C.M., Li G., Zhang-Salomons J., Mackillop W.J. The impact of socioeconomic status on stage of cancer at diagnosis and survival. Cancer 2010, 116:4160-4167.
14. Bravo L.E., García L.S., Collazos P.A. Cancer survival in Cali, Colombia: a population-based study, 1995-2004. Colomb. Méd. Cali Colomb. 2014, 45:110-116.
15. Bray F., Ren J.-S., Masuyer E., Ferlay J. Global estimates of cancer prevalence for 27 sites in the adult population in 2008. Int. J. Cancer 2013, 132:1133-1145.
16. Burns R.M., Sharp L., Sullivan F.J., Deady S.E., Drummond F.J., O Neill C. Factors driving inequality in prostate cancer survival: a population based study. PLoS One 2014, 9:e106456.
17. Byers T.E., Wolf H.J., Bauer K.R., Bolick-Aldrich S., Chen V.W., Finch J.L., Fulton J.P., Schymura M.J., Shen T., Van Heest S., Yin X. The impact of socioeconomic status on survival after cancer in the United States: findings from the National Program of Cancer Registries Patterns of Care Study. Cancer 2008, 113:582-591. for the Patterns of Care Study Group.
18. Chang C.M., Su Y.C., Lai N.S., Huang K.Y., Chien S.H., Chang Y.H., Lian W.C., Hsu T.W., Lee C.C. The combined effect of individual and neighborhood socioeconomic status on cancer survival rates. PLoS One 2012, 7:e44325.
19. Chu D.I., Freedland S.J. Prostate cancer. Socioeconomic status and disparities in treatment patterns. Nat. Rev. Urol. 2010, 7:480-481.
20. Clarke N.W. Survival from prostate cancer in England and Wales up to 2001. Br. J. Cancer 2008, 99:S78-S79.
21. Clegg L.X., Reichman M.E., Miller B.A., Hankey B.F., Singh G.K., Lin Y.D., Goodman M.T., Lynch C.F., Schwartz S.M., Chen V.W., Bernstein L., Gomez S.L., Graff J.J., Lin C.C., Johnson N.J., Edwards B.K. Impact of socioeconomic status on cancer incidence and stage at diagnosis: selected findings from the surveillance, epidemiology, and end results: National Longitudinal Mortality Study. Cancer Causes Control 2009, 20:417-435.
22. Coleman M.P., Rachet B., Woods L.M., Mitry E., Riga M., Cooper N., Quinn M.J., Brenner H., Estève J. Trends and socioeconomic inequalities in cancer survival in England and Wales up to 2001. Br. J. Cancer 2004, 90:1367-1373.
23. Davies N.J., Batehup L., Thomas R. The role of diet and physical activity in breast, colorectal, and prostate cancer survivorship: a review of the literature. Br. J. Cancer 2011, 105(Suppl. 1):S52-S73.
24. Davis T.C., Williams M.V., Marin E., Parker R.M., Glass J. Health literacy and cancer communication. CA Cancer J. Clin. 2002, 52:134-149.
25. De Angelis R., Sant M., Coleman M.P., Francisci S., Baili P., Pierannunzio D., Trama A., Visser O., Brenner H., Ardanaz E., Bielska-Lasota M., Engholm G., Nennecke A., Siesling S., Berrino F., Capocaccia R. Cancer survival in Europe 1999-2007 by country and age: results of EUROCARE-5-a population-based study. Lancet Oncol. 2014, 15:23-34. EUROCARE-5 Working Group.
26. De Vries E., Karim-Kos H.E., Janssen-Heijnen M.L.G., Soerjomataram I., Kiemeney L.A., Coebergh J.W.W. Explanations for worsening cancer survival. Nat. Rev. Clin. Oncol. 2010, 7:60-63.
27. Dickman P.W., Adami H.-O. Interpreting trends in cancer patient survival. J. Intern. Med. 2006, 260:103-117.
28. Dutta Roy S., Philip J., Javle P. Trends in prostate cancer incidence and survival in various socioeconomic classes: a population-based study. Int. J. Urol. 2005, 12:644-653.
29. Du X.L., Fang S., Coker A.L., Sanderson M., Aragaki C., Cormier J.N., Xing Y., Gor B.J., Chan W. Racial disparity and socioeconomic status in association with survival in older men with local/regional stage prostate carcinoma: findings from a large community-based cohort. Cancer 2006, 106:1276-1285.
30. Ellis L., Coleman M.P., Rachet B. How many deaths would be avoidable if socioeconomic inequalities in cancer survival in England were eliminated? A national population-based study, 1996-2006. Eur. J. Cancer 2012, 48:270-278.
31. Elstad J.I., Torstensrud R., Lyngstad T.H., Kravdal O. Trends in educational inequalities in mortality, seven types of cancers, Norway 1971-2002. Eur. J. Public Health 2011, 22:771-776.
32. Faggiano F., Partanen T., Kogevinas M., Boffetta P. Socioeconomic differences in cancer incidence and mortality. Social Inequalities and Cancer 1997, 65-176. IARC Sci., Lyon, Publ. No. 138. M. Kogevinas, N. Pearce, M. Susser, P. Boffetta (Eds.).
33. Fairley L., Baker M., Whiteway J., Cross W., Forman D. Trends in non-metastatic prostate cancer management in the Northern and Yorkshire region of England, 2000-2006. Br. J. Cancer 2009, 101:1839-1845.
34. Feinstein A.R., Sosin D.M., Wells C.K. The Will Rogers phenomenon. Stage migration and new diagnostic techniques as a source of misleading statistics for survival in cancer. N. Engl. J. Med. 1985, 312:1604-1608.
35. Frederiksen B.L., Osler M., Harling H., Ladelund S., Jørgensen T. Do patient characteristics, disease, or treatment explain social inequality in survival from colorectal cancer?. Soc. Sci. Med. 2009, 69:1107-1115.
36. Freeman V.L., Ricardo A.C., Campbell R.T., Barrett R.E., Warnecke R.B. Association of census tract-level socioeconomic status with disparities in prostate cancer-specific survival. Cancer Epidemiol. Biomark Prevent. 2011, 20:2150-2159.
37. Gaston C.M., Mitchell G. Information giving and decision-making in patients with advanced cancer: a systematic review. Soc. Sci. Med. 2005, 61:2252-2264. 1982.
38. Gilligan T. Social disparities and prostate cancer: mapping the gaps in our knowledge. Cancer Causes Control 2005, 16:45-53.
39. Goddard M., Smith P. Equity of access to health care services: theory and evidence from the UK. Soc. Sci. Med. 2001, 53:1149-1162.
40. Gomella L.G., Liu X.S., Trabulsi E.J., Kelly W.K., Myers R., Showalter T., Dicker A., Wender R. Screening for prostate cancer: the current evidence and guidelines controversy. Can. J. Urol. 2011, 18:5875-5883.
41. Hall S.E., Holman C.D.J., Wisniewski Z.S., Semmens J. Prostate cancer: socio-economic, geographical and private-health insurance effects on care and survival. BJU Int. 2005, 95:51-58.
42. Hall W.H., Jani A.B., Ryu J.K., Narayan S., Vijayakumar S. The impact of age and comorbidity on survival outcomes and treatment patterns in prostate cancer. Prostate Cancer Prostatic Dis. 2005, 8:22-30.
43. Hansen R.P., Olesen F., Sørensen H.T., Sokolowski I., Søndergaard J. Socioeconomic patient characteristics predict delay in cancer diagnosis: a Danish cohort study. BMC Health Serv. Res. 2008, 8:49.
44. Harvei S., Kravdal O. The importance of marital and socioeconomic status in incidence and survival of prostate cancer. An analysis of complete Norwegian birth cohorts. Prev. Med. 1997, 26:623-632.
45. Hayen A., Smith D.P., Patel M.I., O'Connell D.L. Patterns of surgical care for prostate cancer in NSW, 1993-2002: rural/urban and socio-economic variation. Aust. N. Z. J. Public Health 2008, 32:417-420.
46. Haynes R., Pearce J., Barnett R. Cancer survival in New Zealand: ethnic, social and geographical inequalities. Soc. Sci. Med. 2008, 67:928-937. 1982.
47. Hellenthal N.J., Parikh-Patel A., Bauer K., Ralph W., deVere W., Koppie T.M. Men of higher socioeconomic status have improved outcomes after radical prostatectomy for localized prostate cancer. Urology 2010, 76:1409-1413.
48. Hussain S.K., Lenner P., Sundquist J., Hemminki K. Influence of education level on cancer survival in Sweden. Ann. Oncol. 2008, 19:156-162.
49. Jansen L., Eberle A., Emrich K., Gondos A., Holleczek B., Kajuter H., Maier W., Nennecke A., Pritzkuleit R., Brenner H. Socioeconomic deprivation and cancer survival in Germany: an ecological analysis in 200 districts in Germany. Int. J. Cancer 2014, 134:2951-2960.
50. Jeffreys M., Sarfati D., Stevanovic V., Tobias M., Lewis C., Pearce N., Blakely T. Socioeconomic inequalities in cancer survival in New Zealand: the role of extent of disease at diagnosis. Cancer Epidemiol. Biomark Prevent. 2009, 18:915-921.
51. Johansson E., Steineck G., Holmberg L., Johansson J.-E., Nyberg T., Ruutu M., Bill-Axelson A. Long-term quality-of-life outcomes after radical prostatectomy or watchful waiting: the Scandinavian Prostate Cancer Group-4 randomised trial. Lancet Oncol. 2011, 12:891-899. SPCG-4 Investigators.
52. Kogevinas M., Porta M. Socioeconomic differences in cancer survival: a review of the evidence. Social Inequalities and Cancer 1997, 177-206. IARC Sci., Lyon, Publ. No. 138. M. Kogevinas, N. Pearce, M. Susser, P. Boffetta (Eds.).
53. Kravdal H. Widening educational differences in cancer survival in Norway. Eur. J. Public Health 2013, 24:270-275.
54. Kravdal O. Social inequalities in cancer survival. Popul. Stud. 2000, 54:1-18.
55. Kravdal Ø. The impact of marital status on cancer survival. Soc. Sci. Med. 2001, 52:357-368.
56. Kravdal Ø. The poorer cancer survival among the unmarried in Norway: is much explained by comorbidities?. Soc. Sci. Med. 2013, 81:42-52.
57. Krieger N., Chen J.T., Kosheleva A., Waterman P.D. Shrinking, widening, reversing, and stagnating trends in US socioeconomic inequities in cancer mortality for the total, black, and white populations: 1960-2006. Cancer Causes Control 2012, 23:297-319.
58. Krupski T.L., Kwan L., Afifi A.A., Litwin M.S. Geographic and socioeconomic variation in the treatment of prostate cancer. J. Clin. Oncol. 2005, 23:7881-7888.
59. Lin D.W., Porter M., Montgomery B. Treatment and survival outcomes in young men diagnosed with prostate cancer: a population-based cohort study. Cancer 2009, 115:2863-2871.
60. Liu L., Coker A.L., Du X.L., Cormier J.N., Ford C.E., Fang S. Long-term survival after radical prostatectomy compared to other treatments in older men with local/regional prostate cancer. J. Surg. Oncol. 2008, 97:583-591.
61. Li X., Sundquist K., Sundquist J. Neighborhood deprivation and prostate cancer mortality: a multilevel analysis from Sweden. Prostate Cancer Prostatic Dis. 2012, 15:128-134.
62. Louwman W.J., Aarts M.J., Houterman S., van Lenthe F.J., Coebergh J.W.W., Janssen-Heijnen M.L.G. A 50% higher prevalence of life-shortening chronic conditions among cancer patients with low socioeconomic status. Br. J. Cancer 2010, 103:1742-1748.
63. Luo Q., Yu X.Q., Cooke-Yarborough C., Smith D.P., O'Connell D.L. Characteristics of cases with unknown stage prostate cancer in a population-based cancer registry. Cancer Epidemiol. 2013, 37:813-819.
64. Lyratzopoulos G., Abel G.A., Brown C.H., Rous B.A., Vernon S.A., Roland M., Greenberg D.C. Socio-demographic inequalities in stage of cancer diagnosis: evidence from patients with female breast, lung, colon, rectal, prostate, renal, bladder, melanoma, ovarian and endometrial cancer. Ann. Oncol. 2013, 24:843-850.
65. Lyratzopoulos G., Barbiere J.M., Greenberg D.C., Wright K.A., Neal D.E. Population based time trends and socioeconomic variation in use of radiotherapy and radical surgery for prostate cancer in a UK region: continuous survey. BMJ 2010, 340:c1928.
66. Macleod U., Mitchell E.D., Burgess C., Macdonald S., Ramirez A.J. Risk factors for delayed presentation and referral of symptomatic cancer: evidence for common cancers. Br. J. Cancer 2009, 101(Suppl. 2):S92-S101.
67. Marmot M., Allen J., Goldblatt P. A social movement, based on evidence, to reduce inequalities in health. Soc. Sci. Med. 2010, 71:1254-1258.
68. Marmot M., Allen J., Bell R., Bloomer E., Goldblatt P. WHO European review of social determinants of health and the health divide. Lancet 2012, 380:1011-1029. Consortium for the European Review of Social Determinants of Health and the Health Divide.
69. Marsa K., Johnsen N.F., Bidstrup P.E., Johannesen-Henry C.T., Friis S. Social inequality and incidence of and survival from male genital cancer in a population-based study in Denmark, 1994-2003. Eur. J. Cancer 2008, 44:2018-2029.
70. McPhail S., Elliss-Brookes L., Shelton J., Ives A., Greenslade M., Vernon S., Morris E.J.A., Richards M. Emergency presentation of cancer and short-term mortality. Br. J. Cancer 2013, 109:2027-2034.
71. Menvielle G., Kunst A.E., Stirbu I., Strand B.H., Borrell C., Regidor E., Leclerc A., Esnaola S., Bopp M., Lundberg O., Artnik B., Costa G., Deboosere P., Martikainen P., Mackenbach J.P. Educational differences in cancer mortality among women and men: a gender pattern that differs across Europe. Br. J. Cancer 2008, 98:1012-1019.
72. Miki Y., Inoue M., Ikeda A., Sawada N., Nakaya T., Shimazu T., Iwasaki M., Yamaji T., Sasazuki S., Shibuya K., Tsugane S. Neighborhood deprivation and risk of cancer incidence, mortality and survival: results from a population-based cohort study in Japan. PLoS One 2014, 9:e106729. JPHC Study Group.
73. Moher D., Liberati A., Tetzlaff J., Altman D.G. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann. Intern. Med. 2009, 151:264-269. 10.7326/0003-4819-151-4-200908180-00135.
74. Movsas A., Ibrahim R., Elshaikh M.A., Lamerato L., Lu M., Sitarik A., Pradhan D., Walker E.M., Stricker H., Freytag S.O., Chetty I.J., Movsas B., Siddiqui F. Do sociodemographic factors influence outcome in prostate cancer patients treated with external beam radiation therapy?. Am. J. Clin. Oncol. 2014, [Epub ahead of print]. 10.1097/COC.0000000000000093.
75. National Cancer Intelligence Network Cancer Incidence by Deprivation. England, 1995-2004 2009, London, 2009.
76. Neal D.E., Donovan J.L., Martin R.M., Hamdy F.C. Screening for prostate cancer remains controversial. Lancet 2009, 374:1482-1483.
77. Neal R.D., Allgar V.L. Sociodemographic factors and delays in the diagnosis of six cancers: analysis of data from the National Survey of NHS Patients: cancer. Br. J. Cancer 2005, 92:1971-1975.
78. Niu X., Pawlish K.S., Roche L.M. Cancer survival disparities by race/ethnicity and socioeconomic status in New Jersey. J. Health Care Poor Underserved 2010, 21:144-160.
79. Papa N., Lawrentschuk N., Muller D., MacInnis R., Ta A., Severi G., Millar J., Syme R., Giles G., Bolton D. Rural residency and prostate cancer specific mortality: results from the Victorian Radical Prostatectomy Register. Aust. N. Z. J. Public Health 2014, 38:449-454.
80. Pitman M., Korets R., Kates M., Hruby G.W., McKiernan J.M. Socioeconomic and clinical factors influence the interval between positive prostate biopsy and radical prostatectomy. Urology 2012, 80:1027-1032.
81. Pokhrel A., Martikainen P., Pukkala E., Rautalahti M., Seppä K., Hakulinen T. Education, survival and avoidable deaths in cancer patients in Finland. Br. J. Cancer 2010, 103:1109-1114.
82. Prasad S.M., Eggener S.E., Lipsitz S.R., Irwin M.R., Ganz P.A., Hu J.C. Effect of depression on diagnosis, treatment, and mortality of men with clinically localized prostate cancer. J. Clin. Oncol. 2014, 32:2471-2478.
83. Quaglia A., Lillini R., Mamo C., Ivaldi E., Vercelli M. Socio-economic inequalities: a review of methodological issues and the relationships with cancer survival. Crit. Rev. Oncol. Hematol. 2013, 85:266-277. SEIH (Socio-Economic Indicators, Health) Working Group.
84. Rachet B., Ellis L., Maringe C., Chu T., Nur U., Quaresma M., Shah A., Walters S., Woods L., Forman D., Coleman M.P. Socioeconomic inequalities in cancer survival in England after the NHS cancer plan. Br. J. Cancer 2010, 103:446-453.
85. Rapiti E., Fioretta G., Schaffar R., Neyroud-Caspar I., Verkooijen H.M., Schmidlin F., Miralbell R., Zanetti R., Bouchardy C. Impact of socioeconomic status on prostate cancer diagnosis, treatment, and prognosis. Cancer 2009, 115:5556-5565.
86. Redaniel M.T., Martin R.M., Gillatt D., Wade J., Jeffreys M. Time from diagnosis to surgery and prostate cancer survival: a retrospective cohort study. BMC Cancer 2013, 13:559.
87. Robbins A.S., Koppie T.M., Gomez S.L., Parikh-Patel A., Mills P.K. Differences in prognostic factors and survival among white and Asian men with prostate cancer, California, 1995-2004. Cancer 2007, 110:1255-1263.
88. Robbins A.S., Yin D., Parikh-Patel A. Differences in prognostic factors and survival among White men and Black men with prostate cancer, California, 1995-2004. Am. J. Epidemiol. 2007, 166:71-78.
89. Robb K., Stubbings S., Ramirez A., Macleod U., Austoker J., Waller J., Hiom S., Wardle J. Public awareness of cancer in Britain: a population-based survey of adults. Br. J. Cancer 2009, 101:S18-S23.
90. Ross L.E., Taylor Y.J., Howard D.L. Trends in prostate-specific antigen test use, 2000-2005. Public Health Rep. 2011, 126:228-239.
91. Rowan S., Rachet B., Alexe D.M., Cooper N., Coleman M.P. Survival from prostate cancer in England and Wales up to 2001. Br. J. Cancer 2008, 99:S75-S77.
92. Rutherford M.J., Hinchliffe S.R., Abel G.A., Lyratzopoulos G., Lambert P.C., Greenberg D.C. How much of the deprivation gap in cancer survival can be explained by variation in stage at diagnosis: an example from breast cancer in the east of England. Int. J. Cancer 2013, 133:2192-2200.
93. Sarfati D., Blakely T., Pearce N. Measuring cancer survival in populations: relative survival vs cancer-specific survival. Int. J. Epidemiol. 2010, 39:598-610.
94. Schrijvers C.T., Mackenbach J.P. Cancer patient survival by socioeconomic status in seven countries: a review for six common cancer sites [corrected]. J. Epidemiol. Community Health 1994, 48:441-446.
95. Schrijvers C.T., Mackenbach J.P., Lutz J.M., Quinn M.J., Coleman M.P. Deprivation, stage at diagnosis and cancer survival. Int. J. Cancer 1995, 63:324-329.
96. Schwartz K., Powell I.J., Underwood W., George J., Yee C., Banerjee M. Interplay of race, socioeconomic status, and treatment on survival of patients with prostate cancer. Urology 2009, 74:1296-1302.
97. Shack L.G., Rachet B., Brewster D.H., Coleman M.P. Socioeconomic inequalities in cancer survival in Scotland 1986-2000. Br. J. Cancer 2007, 97:999-1004.
98. Shafique K., Morrison D.S. Socio-economic inequalities in survival of patients with prostate cancer: role of age and Gleason grade at diagnosis. PLoS One 2013, 8:e56184.
99. Shafique K., Oliphant R., Morrison D.S. The impact of socio-economic circumstances on overall and grade-specific prostate cancer incidence: a population-based study. Br. J. Cancer 2012, 107:575-582.
100. Shafique K., Proctor M.J., McMillan D.C., Leung H., Smith K., Sloan B., Morrison D.S. The modified Glasgow prognostic score in prostate cancer: results from a retrospective clinical series of 744 patients. BMC Cancer 2013, 13:292.
101. Shafique K., Proctor M.J., McMillan D.C., Qureshi K., Leung H., Morrison D.S. Systemic inflammation and survival of patients with prostate cancer: evidence from the Glasgow inflammation outcome study. Prostate Cancer Prostatic Dis. 2012, 15:195-201.
102. Skalicka V., van Lenthe F., Bambra C., Krokstad S., Mackenbach J. Material, psychosocial, behavioural and biomedical factors in the explanation of relative socio-economic inequalities in mortality: evidence from the HUNT study. Int. J. Epidemiol. 2009, 38:1272-1284.
103. Sloggett A., Young H., Grundy E. The association of cancer survival with four socioeconomic indicators: a longitudinal study of the older population of England and Wales 1981-2000. BMC Cancer 2007, 7:20.
104. Spencer B.A., Steinberg M., Malin J., Adams J., Litwin M.S. Quality-of-care indicators for early-stage prostate cancer. J. Clin. Oncol. 2003, 21:1928-1936.
105. Tewari A., Horninger W., Pelzer A.E., Demers R., Crawford E.D., Gamito E.J., Divine G., Johnson C.C., Bartsch G., Menon M. Factors contributing to the racial differences in prostate cancer mortality. BJU Int. 2005, 96:1247-1252.
106. Tewari A.K., Gold H.T., Demers R.Y., Johnson C.C., Yadav R., Wagner E.H., Yood M.U., Field T.S., Divine G., Menon M. Effect of socioeconomic factors on long-term mortality in men with clinically localized prostate cancer. Urology 2009, 73:624-630.
107. Tewari A., Raman J.D., Chang P., Rao S., Divine G., Menon M. Long-term survival probability in men with clinically localized prostate cancer treated either conservatively or with definitive treatment (radiotherapy or radical prostatectomy). Urology 2006, 68:1268-1274.
108. Tyson M.D., Andrews P.E., Etzioni D.A., Ferrigni R.G., Humphreys M.R., Swanson S.K., Castle E.K. Marital status and prostate cancer outcomes. Can. J. Urol. 2013, 20:6702-6706.
109. Van den Bergh R.C.N., Albertsen P.C., Bangma C.H., Freedland S.J., Graefen M., Vickers A., van der Poel H.G. Timing of curative treatment for prostate cancer: a systematic review. Eur. Urol. 2013, 64:204-215.
110. Van der Heide I., Rademakers J., Schipper M., Droomers M., Sørensen K., Uiters E. Health literacy of Dutch adults: a cross sectional survey. BMC Public Health 2013, 13:179.
111. Williams N., Hughes L.J., Turner E.L., Donovan J.L., Hamdy F.C., Neal D.E., Martin R.M., Metcalfe C. Prostate-specific antigen testing rates remain low in UK general practice: a cross-sectional study in six English cities. BJU Int. 2011, 108:1402-1408.
112. Wiegel T., Albers P., Bussar-Maatz R., Gottberg A., Härter M., Kieser M., Kristiansen G., Nettekoven G., Martus P., Schmidberger H., Wellek S., Stöckle M. PREFERE - the German prostatic cancer study: questions and claims surrounding study initiation in January 2013. Urology 2013, 52:576-579.
113. Wilt T.J., Brawer M.K., Jones K.M., Barry M.J., Aronson W.J., Fox S., Gingrich J.R., Wei J.T., Gilhooly P., Grob B.M., Nsouli I., Iyer P., Cartagena R., Snider G., Roehrborn C., Sharifi R., Blank W., Pandya P., Andriole G.L., Culkin D., Wheeler T. Radical prostatectomy versus observation for localized prostate cancer. N. Engl. J. Med. 2012, 367:203-213. Prostate Cancer Intervention versus Observation Trial (PIVOT) Study Group.
114. Woods L.M., Rachet B., Coleman M.P. Choice of geographic unit influences socioeconomic inequalities in breast cancer survival. Br. J. Cancer 2005, 92:1279-1282.
115. Woods L.M., Rachet B., Coleman M.P. Origins of socio-economic inequalities in cancer survival: a review. Ann. Oncol. 2006, 17:5-19.
116. Yin H.S., Dreyer B.P., Vivar K.L., MacFarland S., van Schaick L., Mendelsohn A.L. Perceived barriers to care and attitudes towards shared decision-making among low socioeconomic status parents: role of health literacy. Acad. Pediatr. 2012, 12:117-124.
117. Yu M., Tatalovich Z., Gibson J.T., Cronin K.A. Using a composite index of socioeconomic status to investigate health disparities while protecting the confidentiality of cancer registry data. Cancer Causes Control 2014, 25:81-92.
118. Yu X.Q., Luo Q., Smith D.P., O'Connell D.L., Baade P.D. Geographic variation in prostate cancer survival in New South Wales. Med. J. Aust. 2014, 200:586-590.
119. Yu X.Q., O'Connell D.L., Gibberd R.W., Armstrong B.K. Assessing the impact of socio-economic status on cancer survival in New South Wales, Australia 1996-2001. Cancer Causes Control 2008, 19:1383-1390.
120. Zhang-Salomons J., Qian H., Holowaty E., Mackillop W.J. Associations between socioeconomic status and cancer survival: choice of SES indicator may affect results. Ann. Epidemiol. 2006, 16:521-528.